Odyssey Health, Inc. (ODYY)
OTCMKTS · Delayed Price · Currency is USD
0.007547
+0.000047 (0.63%)
At close: Nov 10, 2026
Odyssey Health Employees
Odyssey Health had 2 employees as of July 31, 2026. The number of employees did not change compared to the previous year. That makes Odyssey Health the 43,542nd largest employer in the world and 7,171st in the United States.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,864,847
Market Cap
831.82K
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jul 31, 2026 | 2 | 0 | - | 2 | 0 |
| Jul 31, 2025 | 2 | -2 | -50.00% | 2 | 0 |
| Jul 31, 2024 | 4 | -2 | -33.33% | 4 | 0 |
| Jul 31, 2023 | 6 | 2 | 50.00% | 6 | 0 |
| Jul 31, 2022 | 4 | 0 | - | 4 | 0 |
| Jul 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jul 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Biotricity | 46 |
| Escalon Medical | 40 |
| GlucoTrack | 15 |
| ENvue Medical | 14 |
| Vycor Medical | 7 |
| Electromedical Technologies | 6 |
| Ludwig Enterprises | 5 |
| IR-Med | 4 |
Odyssey Health News
- 6 months ago - Odyssey Health, Inc. Secures Exclusive Global Distribution Rights for BreastCheck™ to Drive Recurring Revenue Growth - PRNewsWire
- 11 months ago - Odyssey Health, Inc. Secures Multi-Million-Dollar, Nine-Year Service Contract and Financing Facility for Up to $25 Million - GlobeNewsWire
- 1 year ago - Odyssey Health, Inc., Enters the $26 Billion Breast Cancer Marketplace - GlobeNewsWire
- 1 year ago - Odyssey Health, Inc. to Advance Development of its Save A Life Choking Rescue Device - GlobeNewsWire
- 2 years ago - Odyssey Health, Inc. Strengthens Balance Sheet with $8.7 Million in Net Equity - Accesswire
- 2 years ago - Odyssey Health Closes Asset Sale of its Neurological Drug Technology Pipeline Including Concussion Drug Candidate with Oragenics, Inc. - Accesswire
- 2 years ago - Odyssey Health, Inc. Gains Shareholder Approval for Asset Sale with Oragenics, Inc. - Accesswire
- 2 years ago - Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion - Accesswire